A bioengineered array of 3D microvessels for vascular permeability assay

Microvascular Research

Volumn 91, Issue , 2014, Pages 90-98

  Lee, Hyunjae ^a   Kim, Sudong ^a   Chung, Minhwan ^a   Kim, Jeong Hun ^b   Jeon, Noo Li ^a,c  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 5; PROTEIN ZO1; VASCULAR ENDOTHELIAL CADHERIN;

3D MICROVESSEL; ANGIOGENESIS; ARTICLE; BIOENGINEERING; BIOLOGICAL MODEL; BLOOD VESSEL PERMEABILITY; CELL JUNCTION; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MICROFLUIDICS; MICROVASCULATURE; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN EXPRESSION; RELIABILITY; REPRODUCIBILITY; TIME LAPSE IMAGING; TUMOR VASCULARIZATION;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD; BIOENGINEERING; BLOOD VESSELS; CADHERINS; CAPILLARY PERMEABILITY; CELL COMMUNICATION; CELL LINE, TUMOR; CLAUDIN-5; FIBROBLASTS; FLUORESCEIN-5-ISOTHIOCYANATE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGELS; MICROCIRCULATION; MICROFLUIDIC ANALYTICAL TECHNIQUES; MICROFLUIDICS; MICROVESSELS; NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84892372328     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.12.001     Document Type: Article

References (49)

1. Beller T.C., et al. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J. Biol. Chem. 2004, 279:46129-46134.
2. Booth R., Kim H. Characterization of a microfluidic in vitro model of the blood-brain barrier ([small mu]BBB). Lab Chip 2012, 12:1784-1792.
3. Breslin J.W., et al. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H92-H100.
4. Brett J., et al. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J. Exp. Med. 1989, 169:1977-1991.
5. Burke-Gaffney A., Keenan A.K. Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1 α/β, tumor necrosis factor-α and interferon-γ. Immunopharmacology 1993, 25:1-9.
6. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
7. Carmeliet P., Jain R.K. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug Discov. 2011, 10:417-427.
8. Chiu L.L., et al. Perfusable branching microvessel bed for vascularization of engineered tissues. Proc. Natl. Acad. Sci. 2012, 109:E3414-E3423.
9. Chrobak K.M., et al. Formation of perfused, functional microvascular tubes in vitro. Microvasc. Res. 2006, 71:185-196.
10. Curry F., Joyner W. Modulation of capillary permeability: methods and measurements in individually perfused mammalian and frog microvessels. Endothel. Cells 1988, 1:3-17.
11. Dings R.P., et al. Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization. Clin. Cancer Res. 2007, 13:3395-3402.
12. Dvorak H.F., et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 1995, 146:1029.
13. Flament J., et al. In vivo CEST MR imaging of U87 mice brain tumor angiogenesis using targeted LipoCEST contrast agent at 7T. Magn. Reson. Med. 2013, 69:179-187.
14. Fu B., et al. Test of a two-pathway model for small-solute exchange across the capillary wall. Am. J. Physiol. Heart Circ. Physiol. 1998, 274:H2062-H2073.
15. Gerlowski L.E., Jain R.K. Microvascular permeability of normal and neoplastic tissues. Microvasc. Res. 1986, 31:288-305.
16. Griep L.M., et al. BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed. Microdevices 2012, 1-6.
17. He P., Adamson R.H. Visualization of endothelial clefts and nuclei in living microvessels with combined reflectance and fluorescence confocal microscopy. Microcirculation 1995, 2:267-276.
18. Horvath C.J., et al. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Proc. Natl. Acad. Sci. 1988, 85:9219-9223.
19. Huang C.P., et al. Engineering microscale cellular niches for three-dimensional multicellular co-cultures. Lab Chip 2009, 9:1740-1748.
20. Ito A., et al. Expression of vascular permeability factor (VPFNEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation. Pathol. Int. 1995, 45:715-720.
21. Jacobs M., Levin M. An improved endothelial barrier model to investigate dengue haemorrhagic fever. J. Virol. Methods 2002, 104:173-185.
22. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307:58-62.
23. Kazakoff P., et al. An in vitro model for endothelial permeability: assessment of monolayer integrity. In Vitro Cell. Dev. Biol. Anim. 1995, 31:846-852.
24. Killackey J., et al. Increased permeability of microcarrier-cultured endothelial monolayers in response to histamine and thrombin. A model for the in vitro study of increased vasopermeability. Am. J. Pathol. 1986, 122:50.
25. Kim S., et al. Engineering of functional, perfusable 3D microvascular networks on a chip. Lab Chip 2013, 13:1489-1500.
26. Li G., et al. Permeability of endothelial and astrocyte cocultures: in vitro blood-brain barrier models for drug delivery studies. Ann. Biomed. Eng. 2010, 38:2499-2511.
27. Ma S.H., et al. An endothelial and astrocyte co-culture model of the blood-brain barrier utilizing an ultra-thin, nanofabricated silicon nitride membrane. Lab Chip 2005, 5:74-85.
28. Martins Green M., et al. Chapter 8. An assay system for in vitro detection of permeability in human "endothelium". Methods in Enzymology 2008, vol. 443:137-153. Academic Press. A.C. David (Ed.).
29. McDonald D.M. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am. J. Respir. Crit. Care Med. 2001, 164:S39-S45.
30. Michel C.C., Curry F.E. Microvascular permeability. Physiol. Rev. 1999, 79:703-761.
31. Moya M.L., et al. In vitro perfused human capillary networks. Tissue Eng. Part C Methods 2013, 19(9):730-737.
32. Nagy J., et al. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 2008, 11:109-119.
33. Nakagawa S., et al. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int. 2009, 54:253-263.
34. Nevo N., et al. Increasing endothelial cell permeability improves the efficiency of myocyte adenoviral vector infection. J. Gene Med. 2001, 3:42-50.
35. Nguyen D.-H.T., et al. Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. Proc. Natl. Acad. Sci. 2013, 110:6712-6717.
36. Price G.M., et al. Effect of mechanical factors on the function of engineered human blood microvessels in microfluidic collagen gels. Biomaterials 2010, 31:6182-6189.
37. Song J.W., et al. Anastomosis of endothelial sprouts forms new vessels in a tissue analogue of angiogenesis. Integr. Biol. 2012, 4:857-862.
38. Stephens K.E., et al. Tumor necrosis factor causes increased pulmonary permeability and edema: comparison to septic acute lung injury. Am. J. Respir. Crit. Care Med. 1988, 137:1364-1370.
39. Turner M.R., Pallone T.L. Hydraulic and diffusional permeabilities of isolated outer medullary descending vasa recta from the rat. Am. J. Physiol. Heart Circ. Physiol. 1997, 272:H392-H400.
40. Wang W., et al. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H434-H440.
41. Wang L.-Y., et al. Apelin-13 passes through the ADMA-damaged endothelial barrier and acts on vascular smooth muscle cells. Peptides 2011, 32(12):2436-2443.
42. Wong K.H., et al. Microfluidic models of vascular functions. Annu. Rev. Biomed. Eng. 2012, 14:205-230.
43. Wu M.H., et al. Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules. J. Physiol. 2001, 532:785-791.
44. Yeon J.H., et al. In vitro formation and characterization of a perfusable three-dimensional tubular capillary network in microfluidic devices. Lab Chip 2012, 12:2815-2822.
45. Yuan F., et al. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc. Res. 1993, 45:269-289.
46. Yuan F., et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. 1996, 93:14765-14770.
47. Yuan W., et al. Non-invasive measurement of solute permeability in cerebral microvessels of the rat. Microvasc. Res. 2009, 77:166-173.
48. Zervantonakis I.K., et al. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc. Natl. Acad. Sci. 2012, 109:13515-13520.
49. Zheng Y., et al. In vitro microvessels for the study of angiogenesis and thrombosis. Proc. Natl. Acad. Sci. 2012, 109:9342-9347.